RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 95 filers reported holding RA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $10,672,000 | -46.7% | 451,247 | -32.2% | 1.84% | -23.1% |
| Q2 2019 | $20,018,000 | +30.2% | 665,713 | -3.0% | 2.39% | +29.4% |
| Q1 2019 | $15,378,000 | +5.7% | 686,513 | -14.1% | 1.85% | -6.5% |
| Q4 2018 | $14,553,000 | +130.7% | 799,612 | +129.3% | 1.98% | +195.2% |
| Q3 2018 | $6,308,000 | +55.4% | 348,712 | +25.4% | 0.67% | +28.1% |
| Q3 2017 | $4,060,000 | +21.2% | 278,082 | +55.6% | 0.52% | +42.9% |
| Q2 2017 | $3,350,000 | -30.2% | 178,750 | -20.7% | 0.37% | -34.6% |
| Q1 2017 | $4,797,000 | +24.9% | 225,340 | -10.9% | 0.56% | +31.5% |
| Q4 2016 | $3,842,000 | – | 252,940 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|